Fate Therapeutics Inc (FATE)

Dec 04, 2025

How Fate Therapeutics Inc. stock valuations compare to rivalsWeekly Profit Recap & Reliable Volume Spike Trade Alerts - Newser

Dec 04, 2025

Dec 03, 2025

Why Fate Therapeutics Inc. stock remains on buy listsWatch List & Safe Entry Point Identification - Newser

Dec 03, 2025

Dec 03, 2025

Will Fate Therapeutics Inc. stock benefit from sector rotationJuly 2025 Intraday Action & Verified Swing Trading Watchlists - Newser

Dec 03, 2025

Dec 02, 2025

Published on: 2025-12-02 03:44:47 - Newser

Dec 02, 2025

Dec 01, 2025

Check Out Fate Therapeutics Inc (FATE)’s Trade Data Rather Than the Analysts’ Views - Setenews

Dec 01, 2025

Nov 28, 2025

Fate Therapeutics (NASDAQ:FATE) Stock Price Passes Below 200 Day Moving AverageHere's What Happened - MarketBeat

Nov 28, 2025

Nov 25, 2025

Fate Therapeutics to Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025 - Quiver Quantitative

Nov 25, 2025

Nov 25, 2025

Fate Therapeutics (NASDAQ: FATE) to Present at Piper Sandler 37th Annual Healthcare Event - Stock Titan

Nov 25, 2025

Nov 25, 2025

Here's Why We're A Bit Worried About Fate Therapeutics' (NASDAQ:FATE) Cash Burn Situation - simplywall.st

Nov 25, 2025

Nov 21, 2025

Cantor Fitzgerald Issues Positive Outlook for FATE Earnings - MarketBeat

Nov 21, 2025

Nov 19, 2025

Multi factor analysis applied to Fate Therapeutics Inc.July 2025 Action & Free Growth Oriented Trading Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Tools to monitor Fate Therapeutics Inc. recovery probabilityBuy Signal & Growth Oriented Trade Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Automated trading signals detected on Fate Therapeutics Inc.Short Setup & Accurate Buy Signal Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Will Fate Therapeutics Inc. stock outperform Nasdaq indexQuarterly Portfolio Report & Precise Entry and Exit Recommendations - newser.com

Nov 19, 2025

Nov 19, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), ALX Oncology Holdings (ALXO) and 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail

Nov 19, 2025

Nov 18, 2025

Is Fate Therapeutics Inc. stock undervalued vs historical averagesEarnings Trend Report & Capital Efficient Trade Techniques - newser.com

Nov 18, 2025

Nov 18, 2025

Exit strategy if you’re trapped in Fate Therapeutics Inc.Portfolio Return Summary & Daily Entry Point Trade Alerts - newser.com

Nov 18, 2025

Nov 18, 2025

Fate Therapeutics, Inc. (NASDAQ:FATE) Given Average Rating of "Hold" by Brokerages - MarketBeat

Nov 18, 2025

Nov 18, 2025

Will Fate Therapeutics Inc. see short term momentumEarnings Risk Summary & Real-Time Volume Spike Alerts - newser.com

Nov 18, 2025

Nov 17, 2025

Fate Therapeutics Reports Q3 Loss Amid Restructuring Efforts - TipRanks

Nov 17, 2025

Nov 16, 2025

How sentiment analysis helps forecast Fate Therapeutics Inc.2025 Pullback Review & Free Growth Oriented Trading Recommendations - newser.com

Nov 16, 2025

Nov 16, 2025

Published on: 2025-11-16 18:05:52 - newser.com

Nov 16, 2025

Nov 16, 2025

Will Fate Therapeutics Inc. stock recover faster than market2025 EndofYear Setup & Safe Entry Zone Tips - newser.com

Nov 16, 2025

Nov 16, 2025

Fate Therapeutics (FATE) Receives a Hold from Bank of America Securities - The Globe and Mail

Nov 16, 2025

Nov 16, 2025

Navigating Data Privacy Challenges: Fate Therapeutics’ Battle with Regulatory Compliance and Business Risks - MSN

Nov 16, 2025

Nov 15, 2025

Why Fate Therapeutics Inc. stock remains a top recommendationPortfolio Gains Report & Verified Stock Trade Ideas - newser.com

Nov 15, 2025

Nov 15, 2025

How resilient is Fate Therapeutics Inc. stock in market downturns2025 AllTime Highs & Weekly High Return Opportunities - newser.com

Nov 15, 2025

Nov 15, 2025

Fate Therapeutics (FATE) Reports Q3 Loss, Beats Revenue Estimates - MSN

Nov 15, 2025

Nov 14, 2025

Fate Therapeutics (NASDAQ:FATE) Announces Quarterly Earnings Results - MarketBeat

Nov 14, 2025

Nov 14, 2025

Fate Therapeutics: Q3 Earnings Snapshot - Connecticut Post

Nov 14, 2025

Nov 14, 2025

Analyzing drawdowns of Fate Therapeutics Inc. with statistical tools2025 Fundamental Recap & Free Fast Entry Momentum Trade Alerts - newser.com

Nov 14, 2025

Nov 13, 2025

Needham Maintains Fate Therapeutics(FATE.US) With Hold Rating - 富途牛牛

Nov 13, 2025

Nov 13, 2025

Fate Therapeutics earnings beat by $0.03, revenue topped estimates - Investing.com Canada

Nov 13, 2025

Nov 13, 2025

Fate Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener

Nov 13, 2025

Nov 13, 2025

Fate Therapeutics Q3 net loss widens - MarketScreener

Nov 13, 2025

Nov 13, 2025

Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates - The Manila Times

Nov 13, 2025

Nov 13, 2025

Fate Therapeutics Receives Regulatory Authorization for International Clinical Trials of Off-the-Shelf CAR T-Cell Therapies FT819 and FT836, Expanding Patient Accessibility in Autoimmune and Oncology Indications - Quiver Quantitative

Nov 13, 2025